Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people. (2022)

First Author: Parry H
Attributed to:  COVID-19 Immunity - National Core Study (IMM-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2022.100739

PubMed Identifier: 36075216

Publication URI: http://europepmc.org/abstract/MED/36075216

Type: Journal Article/Review

Volume: 3

Parent Publication: Cell reports. Medicine

Issue: 9

ISSN: 2666-3791